Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea
· Delayed Price · Currency is KRW 19,690
+820 (4.35%)
Apr 1, 2025, 3:30 PM KST
Anterogen.Co.,Ltd. Revenue
In the year 2024, Anterogen.Co.,Ltd. had annual revenue of 6.93B KRW with 6.66% growth. Anterogen.Co.,Ltd. had revenue of 1.79B in the quarter ending December 31, 2024, a decrease of -1.12%.
Revenue
6.93B
Revenue Growth
+6.66%
P/S Ratio
26.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
188.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.93B | 432.62M | 6.66% |
| Dec 31, 2023 | 6.50B | -90.76M | -1.38% |
| Dec 31, 2022 | 6.59B | -1.53B | -18.85% |
| Dec 31, 2021 | 8.12B | 3.97B | 95.64% |
| Dec 31, 2020 | 4.15B | 3.67M | 0.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |